Literature DB >> 9117030

Proteins and phospholipids in BAL from patients with hydrostatic pulmonary edema.

G Nakos1, J Pneumatikos, I Tsangaris, C Tellis, M Lekka.   

Abstract

The purpose of the present study is twofold: to evaluate alterations in total phospholipid content and individual phospholipid classes of the surfactant, and to detect markers of inflammatory reaction in bronchoalveolar lavage (BAL) from patients with hydrostatic pulmonary edema (HPE). Mechanically ventilated patients with HPE (Group 1) were compared with mechanically ventilated patients without cardiopulmonary disease (Group 2), considered as the control group. Group 3, including patients with high-permeability pulmonary edema, was used for further comparison. BAL was obtained and immediately cooled at 4 degrees C. Total proteins, albumin, and platelet-activating factor--acetylhydrolase (PAF-AcH) were measured. Total lipids were extracted and analyzed after thin-layer chromatographic separation. PAF was determined with bioassay. Total BAL proteins and albumin were found significantly higher in patients with HPE compared with control, but were lower compared with adult respiratory distress syndrome (ARDS). PAF was elevated in patients with HPE and ARDS, whereas in the control group it was actually in nondetectable levels. PAF was significantly higher in ARDS than in HPE patients. BAL neutrophils concentration was higher in HPE compared with control, but lower compared with ARDS. There was an inverse correlation between PAF-AcH and PAF. Quantitative reduction of total BAL phospholipids (PL) and qualititative deficiency was observed in both patients with HPE and ARDS. The findings of this study suggest that there is evidence of inflammation in the airspaces of patients with HPE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9117030     DOI: 10.1164/ajrccm.155.3.9117030

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  15 in total

1.  Pressure is proinflammatory in lung venular capillaries.

Authors:  W M Kuebler; X Ying; B Singh; A C Issekutz; J Bhattacharya
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Biochemical parameters of bronchoalveolar lavage fluid in fat embolism.

Authors:  Georgia Karagiorga; George Nakos; Eftychia Galiatsou; Marilena E Lekka
Journal:  Intensive Care Med       Date:  2005-12-02       Impact factor: 17.440

Review 3.  Diffuse Alveolar Hemorrhage in Cardiac Diseases.

Authors:  Biplab K Saha; Woon H Chong
Journal:  Lung       Date:  2021-03-11       Impact factor: 2.584

4.  Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components.

Authors:  G Nakos; E I Kitsiouli; I Tsangaris; M E Lekka
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

5.  Hydrostatic mechanisms may contribute to the pathogenesis of human re-expansion pulmonary edema.

Authors:  Richard D Sue; Michael A Matthay; Lorraine B Ware
Journal:  Intensive Care Med       Date:  2004-07-17       Impact factor: 17.440

6.  Differential expression of platelet-activating factor acetylhydrolase in lung macrophages.

Authors:  Katherine M Howard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-10-16       Impact factor: 5.464

7.  Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury.

Authors:  Jonathan A Kropski; Richard D Fremont; Carolyn S Calfee; Lorraine B Ware
Journal:  Chest       Date:  2009-02-02       Impact factor: 9.410

8.  Pulmonary edema and pleural effusion in norepinephrine-stimulated rats--hemodynamic or inflammatory effect?

Authors:  Beate Rassler; Christian Reissig; Wilfried Briest; Andrea Tannapfel; Heinz-Gerd Zimmer
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

9.  C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome.

Authors:  Konstantinos Kambas; Maciej M Markiewski; Ioannis A Pneumatikos; Stavros S Rafail; Vassiliki Theodorou; Dimitrios Konstantonis; Ioannis Kourtzelis; Michael N Doumas; Paola Magotti; Robert A Deangelis; John D Lambris; Konstantinos D Ritis
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

10.  Immobilization of Lipid Substrates: Application on Phospholipase A2 Determination.

Authors:  Athanassios Karkabounas; Dimitra G Georgiadou; Panagiotis Argitis; Vassilios Psycharis; George Nakos; Agni M Kosmas; Marilena E Lekka
Journal:  Lipids       Date:  2015-10-08       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.